Enzalutamide
Pfizer,Astellas
['pcsm', 'prostate', 'brca', 'crpc']
 presenting excellent data in how #brca mutations predict worse outcomes in patients with prostate cancer. a 10 month os difference in mcrpc. we need to screen all patients with metastatic and high risk disease! - #asco2023 #pcsm 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.